Trade Show

Quince Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

ITNFebruary 6, 2025

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $QNCX #biotech–Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that Dirk Thye, M.D., Quince’s Chief Executive Officer and Chief Medical Officer, will participate in a fireside chat at the Oppenheimer 35th Annual Healthcare Life Sciences Conference, a virtual event, on Wednesday, February 12, 2025 beginning at 2:00 p.m. Easter

ITN

We Live in a T-Shaped World- Broad knowledge across ecosystems is essential, but it’s the deep expertise of Subject Matter Experts (SMEs) that helps organizations leap forward. At IndiaTechnologyNews, we go beyond news, views, and analysis—we showcase SMEs, translating their insights for wider audiences. Write to: editor@indiatechnologynews.in